CELEBRATING 5 YEARS AT CBSET…David joined CBSET in 2017 as Senior Account Executive for Business Development. He has 30 years of biotech and pharma sales experience in therapeutic areas ranging from cardiology, infertility, and oncology to allergy/immunology and patient-reported outcomes. Previous employers include Bristol Meyers Squibb, EMD Serono and Schering-Plough, working within the major academic […]

CELEBRATING 12 YEARS AT CBSET… Dr. Rami Tzafriri provides scientific leadership to CBSET’s cutting-edge translational research programs, leveraging CBSET’s strengths in minimally invasive interventions, histopathology, imaging, bioanalysis and computational modeling to accelerate product development. He also leads CBSET’s educational and technology differentiations mission, and liaises with key opinion leaders. THREE THINGS YOU SHOULD KNOW ABOUT […]

CELEBRATING 10 YEARS AT CBSET… Dr. Williams-Fritze joined CBSET in 2012. She is responsible for developing surgical models and performing procedures to meet Sponsors’ needs and ensuring regulatory compliance with applicable agencies, as well as overall management of the vivarium and oversight and training of CBSET’s technical staff. THREE THINGS YOU SHOULD KNOW ABOUT DR. […]

CELEBRATING 12 YEARS AT CBSET… Dr. Brett Zani joined the CBSET team in 2010. His biomedical research background ranges from molecular cardiology and cancer biology to cardiovascular physiology and tissue regeneration. He holds an MS and PhD in Cellular and Integrative Physiology from Indiana University School of Medicine. TWO THINGS YOU SHOULD KNOW ABOUT DR. […]

CELEBRATING 6 YEARS AT CBSET… Michael joined CBSET in 2016 as Director of Business Development, bringing significant biomedical experience and specialized expertise to the role. Previously, he was employed by Neural Stem Cell Institute (NSCI), where he oversaw development of a cell-based therapy for macular degeneration under an award from the New York Stem Cell […]

CELEBRATING 12 YEARS AT CBSET… Dr. Rami Tzafriri provides scientific leadership to CBSET’s cutting-edge translational research programs, leveraging CBSET’s strengths in minimally invasive interventions, histopathology, imaging, bioanalysis and computational modeling to accelerate product development. He also leads CBSET’s educational and technology differentiations mission, and liaises with key opinion leaders. THREE THINGS YOU SHOULD KNOW ABOUT […]

CELEBRATING 12 YEARS AT CBSET… Dr. John Keating is a Diplomate of the American College of Veterinary Pathology, with years of experience in contract research and preclinical safety evaluations, including gross and microscopic pathology, pathophysiology, specialized staining, and imaging procedures across a variety of device classes and large- and small-animal species, and is well-versed in […]

CELEBRATING 16 YEARS AT CBSET… With broad scientific expertise in both drug and device development, Peter co-founded CBSET in 2006 and, as its CEO, has since led the way in establishing CBSET as the undisputed gold standard for preclinical science in the life sciences industry. THREE THINGS YOU SHOULD KNOW ABOUT PETER M. MARKHAM 1: […]